• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺激素刺激TRANCE并抑制小鼠骨髓培养物中骨保护素信使核糖核酸的表达:与破骨细胞样细胞形成的相关性。

Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.

作者信息

Lee S K, Lorenzo J A

机构信息

V.A. Connecticut Healthcare System, Newington 06111, USA.

出版信息

Endocrinology. 1999 Aug;140(8):3552-61. doi: 10.1210/endo.140.8.6887.

DOI:10.1210/endo.140.8.6887
PMID:10433211
Abstract

We studied the effects of PTH on the expression of tumor necrosis factor-related activation-induced cytokine (TRANCE), osteoprotegerin (OPG), and receptor activator of NF kappaB (RANK) messenger RNA (mRNA) in cultured murine bone marrow, calvaria, and osteoblasts. TRANCE, OPG, and RANK are recently identified regulators of osteoclast formation. Bone marrow cells were cultured with or without PTH(1-34) for 6 days. TRANCE, OPG, and RANK mRNA were measured by RT-PCR. In 6-day cultures, PTH stimulated the number of OCL/well in a dose-dependent manner. A time course showed significant (P < 0.01) increases in OCL/well after 24 h of PTH (100 ng/ml). TRANCE mRNA expression, like OCL formation, increased dose dependently and was maximal, with 10-100 ng/ml PTH. In contrast, OPG mRNA expression was decreased by 0.1 ng/ml PTH (40%) and completely abolished by 1 ng/ml. TRANCE mRNA expression was rapidly stimulated by PTH (maximal response at 1 h, 8.1-fold over control). Expression declined by 40% at 24 h but was still much greater than control at 6 days (4.6-fold) in a time-course study. PTH caused a transient stimulation of OPG mRNA at 1 h (2-fold), which returned to basal levels by 2 h. After 6 h, PTH completely inhibited OPG mRNA. There were only minor effects of PTH on RANK mRNA expression. PTH had less potent effects on TRANCE and OPG mRNA expression in calvaria organ cultures and osteoblasts. In mouse calvaria cultures, TRANCE expression was detectable in controls and was increased 2.9-fold by PTH at 24 h. PTH treatment of calvaria decreased OPG expression by 30% at 6 h. MC3T3 E-1 osteoblastic cells expressed minimal levels of TRANCE mRNA either before or after PTH treatment. OPG mRNA was present in MC3T3 E-1 cells, but levels were not modulated by PTH. In primary osteoblastic cells, PTH stimulated TRANCE mRNA expression 4-fold at 2 h and inhibited OPG mRNA expression by 46%. These results demonstrate a tight correlation between the ability of PTH to stimulate OCL formation in marrow culture and expression of TRANCE (r = 0.87, P < or = 0.05) and OPG mRNA (r = -0.88, P < or = 0.05). Reciprocal regulation of TRANCE and OPG mRNA by PTH preceded its effects on OCL formation by 18-23 h. Hence, it is likely that PTH regulates bone resorption, at least in part, via its effects on TRANCE and OPG expression.

摘要

我们研究了甲状旁腺激素(PTH)对培养的小鼠骨髓、颅骨和成骨细胞中肿瘤坏死因子相关激活诱导细胞因子(TRANCE)、骨保护素(OPG)以及核因子κB受体激活剂(RANK)信使核糖核酸(mRNA)表达的影响。TRANCE、OPG和RANK是最近确定的破骨细胞形成调节因子。将骨髓细胞在有或无PTH(1 - 34)的条件下培养6天。通过逆转录聚合酶链反应(RT-PCR)检测TRANCE、OPG和RANK mRNA。在6天的培养中,PTH以剂量依赖的方式刺激每个孔中破骨细胞(OCL)的数量。时间进程显示,在加入PTH(100 ng/ml)24小时后,每个孔中的OCL数量显著增加(P < 0.01)。TRANCE mRNA表达与OCL形成一样,呈剂量依赖性增加,在PTH浓度为10 - 100 ng/ml时达到最大值。相比之下,0.1 ng/ml的PTH使OPG mRNA表达降低40%,而1 ng/ml的PTH则使其完全消失。PTH能迅速刺激TRANCE mRNA表达(1小时时达到最大反应,比对照高8.1倍)。在一项时间进程研究中,24小时时表达下降40%,但在6天时仍比对照高得多(4.6倍)。PTH在1小时时对OPG mRNA有短暂刺激作用(2倍),2小时时恢复到基础水平。6小时后PTH完全抑制OPG mRNA。PTH对RANK mRNA表达的影响较小。PTH对颅骨器官培养物和成骨细胞中TRANCE和OPG mRNA表达的作用较弱。在小鼠颅骨培养物中,对照中可检测到TRANCE表达,24小时时PTH使其增加2.9倍。PTH处理颅骨6小时后使OPG表达降低30%。MC3T3 E - 1成骨细胞在PTH处理前后TRANCE mRNA表达水平极低。MC3T3 E - 1细胞中有OPG mRNA,但PTH对其水平无调节作用。在原代成骨细胞中,PTH在2小时时刺激TRANCE mRNA表达4倍,并使OPG mRNA表达降低46%。这些结果表明,PTH在骨髓培养物中刺激OCL形成的能力与TRANCE(r = 0.87,P ≤ 0.05)和OPG mRNA(r = -0.88,P ≤ 0.05)的表达之间存在紧密相关性。PTH对TRANCE和OPG mRNA的相互调节作用比其对OCL形成的影响提前18 - 23小时。因此,PTH可能至少部分通过其对TRANCE和OPG表达的影响来调节骨吸收。

相似文献

1
Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.甲状旁腺激素刺激TRANCE并抑制小鼠骨髓培养物中骨保护素信使核糖核酸的表达:与破骨细胞样细胞形成的相关性。
Endocrinology. 1999 Aug;140(8):3552-61. doi: 10.1210/endo.140.8.6887.
2
Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.环磷酸腺苷/蛋白激酶A介导甲状旁腺激素/甲状旁腺激素相关蛋白受体对破骨细胞生成以及骨髓基质细胞中核因子κB受体活化因子配体(RANKL)和骨保护素mRNA表达的调控。
J Bone Miner Res. 2002 Sep;17(9):1667-79. doi: 10.1359/jbmr.2002.17.9.1667.
3
Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.表达重组甲状旁腺激素/甲状旁腺激素相关蛋白受体的SaOS-4/3细胞支持的破骨细胞生成中膜相关或基质相关形式的巨噬细胞集落刺激因子和核因子κB受体活化因子配体/骨保护素的重要性。
J Bone Miner Res. 2000 Sep;15(9):1766-75. doi: 10.1359/jbmr.2000.15.9.1766.
4
PTH differentially regulates expression of RANKL and OPG.甲状旁腺激素(PTH)对核因子κB受体活化因子配体(RANKL)和骨保护素(OPG)的表达具有差异性调节作用。
J Bone Miner Res. 2004 Feb;19(2):235-44. doi: 10.1359/JBMR.0301226. Epub 2003 Dec 16.
5
Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells.一氧化氮调节骨髓基质细胞中核因子-κB受体激活剂配体和骨保护素的表达。
Endocrinology. 2004 Feb;145(2):751-9. doi: 10.1210/en.2003-0726. Epub 2003 Oct 16.
6
Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.高磷酸盐浓度对破骨细胞分化以及骨吸收活性的影响。
J Cell Physiol. 2003 Jul;196(1):180-9. doi: 10.1002/jcp.10270.
7
Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone.Fgf2基因敲除小鼠骨髓培养物中破骨细胞形成受损,对甲状旁腺激素无反应。
J Biol Chem. 2003 Jun 6;278(23):21258-66. doi: 10.1074/jbc.M302113200. Epub 2003 Mar 28.
8
Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.人小梁骨来源的成骨细胞在特定的无血清培养基中可在体外支持人破骨细胞的形成。
J Cell Physiol. 2005 Jun;203(3):573-82. doi: 10.1002/jcp.20255.
9
Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures.甲状旁腺激素对核因子-κB 受体激活剂配体和骨保护素 mRNA 表达的调节主要通过蛋白激酶 A 途径在小鼠骨髓培养物中介导。
Bone. 2002 Jul;31(1):252-9. doi: 10.1016/s8756-3282(02)00804-9.
10
Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.细胞内钙和蛋白激酶C介导成骨细胞中核因子-κB受体激活剂配体和骨保护素的表达。
Endocrinology. 2000 Dec;141(12):4711-9. doi: 10.1210/endo.141.12.7852.

引用本文的文献

1
RANKL Drives Bone Metastasis in Mammary Cancer: Protective Effects of Anti-Resorptive Treatments.RANKL驱动乳腺癌骨转移:抗吸收治疗的保护作用。
Int J Mol Sci. 2025 May 22;26(11):4990. doi: 10.3390/ijms26114990.
2
Sex-dependent variation in bone adaptation: from degeneration to regeneration.骨骼适应性的性别差异:从退化到再生
J Orthop Translat. 2025 May 5;52:325-343. doi: 10.1016/j.jot.2025.04.011. eCollection 2025 May.
3
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes.
再探甲状旁腺疾病中的骨:来自流行病学、手术及新药疗效的证据
Endocr Rev. 2025 Jul 15;46(4):576-620. doi: 10.1210/endrev/bnaf010.
4
Mitochondrial β-oxidation of adipose-derived fatty acids by osteoblasts fuels parathyroid hormone-induced bone formation.成骨细胞中线粒体对脂肪源性脂肪酸的β-氧化作用为甲状旁腺激素诱导的骨形成供能。
JCI Insight. 2023 Mar 22;8(6):e165604. doi: 10.1172/jci.insight.165604.
5
Bone Metastasis of Breast Cancer: Molecular Mechanisms and Therapeutic Strategies.乳腺癌骨转移:分子机制与治疗策略
Cancers (Basel). 2022 Nov 22;14(23):5727. doi: 10.3390/cancers14235727.
6
The role of IL-6 and osteoprotegerin in bone metabolism in patients with Graves' disease.IL-6 和骨保护素在 Graves 病患者骨代谢中的作用。
Turk J Med Sci. 2022 Apr;52(2):338-345. doi: 10.55730/1300-0144.5320. Epub 2022 Apr 14.
7
Parathyroid Hormone on Osteoprotegerin Levels in Patients with Primary Hyperparathyroidism.甲状旁腺激素对原发性甲状旁腺功能亢进症患者骨保护素水平的影响
Eurasian J Med. 2022 Oct;54(3):225-228. doi: 10.5152/eurasianjmed.2021.21197.
8
Osteoporosis and periodontal diseases - An update on their association and mechanistic links.骨质疏松症与牙周疾病——二者关联及机制联系的最新进展
Periodontol 2000. 2022 Jun;89(1):99-113. doi: 10.1111/prd.12422. Epub 2022 Mar 4.
9
Extracellular Vesicles Derived From Murine Cementoblasts Possess the Potential to Increase Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclastogenesis.源自小鼠成牙骨质细胞的细胞外囊泡具有增强核因子κB受体激活剂配体诱导破骨细胞生成的潜力。
Front Physiol. 2022 Feb 14;13:825596. doi: 10.3389/fphys.2022.825596. eCollection 2022.
10
Short Cyclic Regimen With Parathyroid Hormone (PTH) Results in Prolonged Anabolic Effect Relative to Continuous Treatment Followed by Discontinuation in Ovariectomized Rats.与连续给予甲状旁腺激素(PTH)然后停药相比,在去卵巢大鼠中采用甲状旁腺激素短周期治疗方案可产生更持久的合成代谢效应。
J Bone Miner Res. 2022 Apr;37(4):616-628. doi: 10.1002/jbmr.4495. Epub 2022 Jan 20.